RecruitingHead and Neck CancerLung Cancer
ATATcH Alternating Treatment Plans for Advanced Cancer
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunotherapy (pembrolizumab) alone for the initial treatment of patients with advanced lung or head and neck cancers.
Sponsor: Rutgers, The State University of New Jersey
Where it's recruiting
New Jersey
Elizabeth · Hamilton · Jersey City · Lakewood …
Source: ClinicalTrials.gov · NCT05358548 · last updated 2026-04-30